Escolar Documentos
Profissional Documentos
Cultura Documentos
Sheena Aitken, Jennifer Mathieson, Grant McGeoch and Catherine McKeen; Link Technologies Ltd, Bellshill, UK. Tom Brown and Nittaya Gale; ATD Bio Ltd, Southampton, UK. grant@linktech.co.uk
Introduction
Oligonucleotide probes used for qPCR are typically labelled with a fluorescent dye to enable detection of the target sequence. In most cases the probe is a doubly labelled oligo where one dye acts as a fluorophore and the other as a quencher. In order to increase the sensitivity of the PCR assay, it is desirable for the quencher to have no native fluorescence (dark quencher). To ease preparation of probes for use in assays with different fluorophores it would be advantageous to have a quencher capable of quenching a range of fluorophores; to this end we have developed a new non-fluorescent quencher with a broad absorption range. A series of double-dye probes have been synthesised to evaluate the efficiency of a new non-fluorescent quencher when paired with FAM-C7, Cy3, Cy5 and Cy5.5 and for use in RT-PCR. The quencher was evaluated when incorporated at the 5 end of the oligonucleotide. The new quencher was compared to existing commercially available quenchers such as Deep Dark Quencher-1 and Black Hole Quenchers.
Conclusions
From the data it can be seen that the Link-quencher works best when paired with Cy3 and has some activity as a quencher with FAM-C7 and Cy5. Due to the poor overlap with Cy5.5, virtually no activity was seen with this pairing. Some impurities were carried through with the oligos and the quenchers were at the atypical 5 end. Work is currently under way to repeat these experiments with the quencher at the 3 end and the results will be available soon. Although successful for Cy3 the Link-quencher did not perform over as wide a range as anticipated but it does fill a gap between DDQ-1 and DDQ-2. We are currently evaluating other molecules for use as a long-range quencher.
Further Information
For further information please contact Dr Catherine McKeen, Technical Manager, Link Technologies (catherine@linktech.co.uk) or Dr Grant McGeoch, NPI Team Leader, Link Technologies Ltd (grant@linktech.co.uk). Cy3, Cy5 and Cy5.5 are trademarks of GE Healthcare. Black
Experimental
Conditions for Taqman Assay
Experiments were carried out with the Taqman probe and no target as a negative control. All reactions were carried out in duplicate.
Hole Quencher, BHQ-1 and BHQ-2 are trademarks of Biosearch Technologies, Inc. www.linktech.co.uk
Thermal protocol:
Activation of the enzyme: 95C/15min Cycles (40 cycle): 95C/5s, 55C/30s, 70C/30s Record at 55C in each cycle
300
400